<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Microbiology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Microbiology</JournalTitle>
      <Issn>2008-3289</Issn>
      <Volume>5</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Low Prevalence of Brucella agglutinins in Blood Donors in Central Province of Iran</title>
    <FirstPage>24</FirstPage>
    <LastPage>27</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Masoomeh</FirstName>
        <LastName>Sofian</LastName>
        <affiliation locale="en_US">Tuberculosis and Pediatric Infectious Research Center, Arak University of Medical Sciences, Arak, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mehrnoosh</FirstName>
        <LastName>Sheikholeslami</LastName>
        <affiliation locale="en_US">Arak University of Medical Sciences, Arak, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Fatemeh-Alsadat</FirstName>
        <LastName>Mahdaviani</LastName>
        <affiliation locale="en_US">Blood Transfusion Organization Research Center, Advanced Institute for Research and Education in Transfusion Medicine, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Arezoo</FirstName>
        <LastName>Aghakhani</LastName>
        <affiliation locale="en_US">Clinical Research Dept., Pasteur Institute of Iran, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Banifazl</LastName>
        <affiliation locale="en_US">Iranian Society for Support of Patients with Infectious Disease, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Eslamifar</LastName>
        <affiliation locale="en_US">Clinical Research Dept., Pasteur Institute of Iran, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hossein</FirstName>
        <LastName>Sarmadian</LastName>
        <affiliation locale="en_US">Tuberculosis and Pediatric Infectious Research Center, Arak University of Medical Sciences, Arak, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ghorban</FirstName>
        <LastName>Deiri</LastName>
        <affiliation locale="en_US">Blood Transfusion Organization Research Center, Advanced Institute for Research and Education in Transfusion Medicine, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Amitis</FirstName>
        <LastName>Ramezani</LastName>
        <affiliation locale="en_US">Clinical Research Dept., Pasteur Institute of Iran, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background and Objective: Brucellosis is a zoonotic disease of worldwide distribution and has great economic importance. Despite its control in many countries, it remains endemic in Iran. Brucellosis was investigated in many high risk occupational groups; however, few studies on the prevalence of brucellosis among blood donors are available. To determine the seroprevalence of brucellosis antibodies in blood donors, a serological study was carried out in central province of Iran. 
Materials and Methods: A total of 897 healthy blood donors with mean age 37.23 &#xB1; 10.9 years were enrolled in the study. Laboratory tests including Standard Tube Agglutination Test (STA) and 2-mercaptoethanol (2ME) agglutination were checked in all samples. STA dilution &#x2265; 1:80, and in the presence of 2-mercaptoethanol (2ME) agglutination &#x2265; 20 was considered positive.
Results: Out of 897 cases, 11.9% were inhabitants of rural areas. 41.5% had history of consumption of unpasteurized dairy products and 9.3% had history of contact with domestic animals. A very low level of Brucella agglutinins was present in 3(0.33%) of the samples and only one sample (0.11%) was found to be truly positive for Brucella agglutinins. 2ME was negative in all samples. None of these 4 subjects showed signs and symptoms of brucellosis in 6 months follow-up. 
Conclusion: On the basis of our data, brucellosis has no epidemiological and clinical importance in our blood donors; therefore, it is not recommended to perform screening tests such as, STA and 2ME to identify brucellosis antibodies in the sera of blood donors.</abstract>
    <web_url>https://ijm.tums.ac.ir/index.php/ijm/article/view/657</web_url>
    <pdf_url>https://ijm.tums.ac.ir/index.php/ijm/article/download/657/429</pdf_url>
  </Article>
</Articles>
